ZA873928B - Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease - Google Patents

Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease

Info

Publication number
ZA873928B
ZA873928B ZA873928A ZA873928A ZA873928B ZA 873928 B ZA873928 B ZA 873928B ZA 873928 A ZA873928 A ZA 873928A ZA 873928 A ZA873928 A ZA 873928A ZA 873928 B ZA873928 B ZA 873928B
Authority
ZA
South Africa
Prior art keywords
topical
treatment
hyperproliferative epithelial
epithelial disease
methotrexate
Prior art date
Application number
ZA873928A
Other languages
English (en)
Inventor
Gerald D Weinstein
D Weinstein Gerald
Jerry L Mccullough
L Mccullough Jerry
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Priority to ZA873928A priority Critical patent/ZA873928B/xx
Publication of ZA873928B publication Critical patent/ZA873928B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
ZA873928A 1986-05-30 1987-06-02 Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease ZA873928B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ZA873928A ZA873928B (en) 1986-05-30 1987-06-02 Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86893686A 1986-05-30 1986-05-30
ZA873928A ZA873928B (en) 1986-05-30 1987-06-02 Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease

Publications (1)

Publication Number Publication Date
ZA873928B true ZA873928B (en) 1988-02-24

Family

ID=25352598

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA873928A ZA873928B (en) 1986-05-30 1987-06-02 Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease

Country Status (9)

Country Link
EP (1) EP0247900B1 (fr)
JP (1) JPS6327432A (fr)
AT (1) ATE70444T1 (fr)
CA (1) CA1300508C (fr)
DE (1) DE3775278D1 (fr)
DK (1) DK277387A (fr)
ES (1) ES2038663T3 (fr)
NZ (1) NZ220495A (fr)
ZA (1) ZA873928B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2808492A (en) * 1991-10-26 1993-05-21 East Riding Laboratories Limited Medicament composition for topical application
WO1998031369A1 (fr) * 1997-01-16 1998-07-23 Sekisui Chemical Co., Ltd. Preparations a usage externe a absorption percutanee
KR100439204B1 (ko) * 2000-10-25 2004-07-07 주식회사 삼양사 메토트렉세이트를 유효성분으로 함유하는 경피투여용 조성물
BR102012009350B1 (pt) * 2012-04-20 2020-12-29 Biolab Sanus Farmacêutica Ltda composição farmacêutica tópica, processo de produção da composição farmacêutica tópica e uso da composição farmacêutica tópica
EP3694521A4 (fr) * 2017-12-05 2021-07-07 Shilpa Medicare Limited Solution topique de méthotrexate pour le traitement du psoriasis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1553310A (en) * 1975-06-19 1979-09-26 Nelson Res & Dev Vehicle composition containing 1-substituted azacycloalkan-2-ones
GB2143433A (en) * 1983-06-20 1985-02-13 Hariprasad Manibhai Patel Methotrexate ointment
US4557934A (en) * 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
US4743588A (en) * 1984-06-13 1988-05-10 Allergan Pharmaceuticals, Inc. Compositions and methods of enhancing transdermal and transmembrane penetration systemic agents

Also Published As

Publication number Publication date
DK277387A (da) 1987-12-01
EP0247900A1 (fr) 1987-12-02
EP0247900B1 (fr) 1991-12-18
JPS6327432A (ja) 1988-02-05
DK277387D0 (da) 1987-05-29
NZ220495A (en) 1990-07-26
ES2038663T3 (es) 1993-08-01
CA1300508C (fr) 1992-05-12
DE3775278D1 (de) 1992-01-30
ATE70444T1 (de) 1992-01-15

Similar Documents

Publication Publication Date Title
AU2118488A (en) Improvements in or relating to methods of treating damaged skin
OA08581A (en) Treatment of diseases caused by retroviruses.
EP0151989A3 (en) Means for the treatment of cardiac diseases
IL56149A (en) 13-halo and 13-deoxy derivatives of c-076 compounds,their preparation and method for the treatment of parasitic infections in animals therewith
AU1808488A (en) Compounds for the treatment of alzheimer's disease
DK0430045T3 (da) Ascorbinsyretocopherylphosphatdiestere til hæmning af Maillards reaktion
PT77898B (en) Process for the preparation of substituted 4-amino-methylenochromanes and 4-aminomethylenecromenes acting on the blood circulation and application thereof in the preparation of pharmaceutical compositions acting on the blood circulation
GB2188547B (en) Tamoxifen composition for the treatment of psoriasis.
GR1002802B (el) Καλλυντικες συνθεσεις και συνθεσεις περιποιησεως του δερματος
ES478967A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7.
JPS57122085A (en) Circulatory disease extirpenter and use
EP0417003A3 (en) Use of antiprogestomimetics for stimulating ovulation
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
ZA873928B (en) Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease
IE870577L (en) Topical amide preparation
DE3373978D1 (en) Composition for the care or treatment of the human skin
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
MY103593A (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
ZA814902B (en) Novel thiazol-2-yl-oxamic acid derivatives,their preparation and therapeutic agents containing these compounds
HU9200400D0 (en) Cinurenic acid derivatives, process for producing them and pharmaceutical compositions containing them
MY103584A (en) 8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it
ATE72397T1 (de) Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.
IE780730L (en) Veterinary composition
GR850484B (fr)
GR3000925T3 (en) 1-fluoro-1-halogeno-dioxa-3,6-bicycloû4.1.0¨heptane, preparation process and use